4/23
08:00 am
mbx
MBX Biosciences to Host In-Person and Virtual Obesity Day on May 11, 2026 to Discuss Expanding Obesity Portfolio
Low
Report
MBX Biosciences to Host In-Person and Virtual Obesity Day on May 11, 2026 to Discuss Expanding Obesity Portfolio
4/22
11:17 am
mbx
Aaron Wealth Makes a Big Bet on MBX Biosciences With a 1.1 Million Share Purchase [Globe and Mail, The (Toronto, Canada)]
Low
Report
Aaron Wealth Makes a Big Bet on MBX Biosciences With a 1.1 Million Share Purchase [Globe and Mail, The (Toronto, Canada)]
4/22
11:11 am
mbx
Aaron Wealth Makes a Big Bet on MBX Biosciences With a 1.1 Million Share Purchase [Yahoo! Finance]
Low
Report
Aaron Wealth Makes a Big Bet on MBX Biosciences With a 1.1 Million Share Purchase [Yahoo! Finance]
4/11
01:00 am
mbx
Medium
Report
4/4
11:25 am
mbx
Does MBX (MBX) Options-Driven Breakout Reveal Deeper Shifts In Its Investment Narrative? [Yahoo! Finance]
Medium
Report
Does MBX (MBX) Options-Driven Breakout Reveal Deeper Shifts In Its Investment Narrative? [Yahoo! Finance]
4/3
08:46 am
mbx
MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
4/3
08:00 am
mbx
MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
4/2
07:32 am
mbx
MBX Biosciences (MBX) was upgraded by Lifesci Capital to "strong-buy".
Medium
Report
MBX Biosciences (MBX) was upgraded by Lifesci Capital to "strong-buy".
3/12
01:03 pm
mbx
MBX Biosciences (MBX) had its "buy" rating reaffirmed by TD Cowen.
Medium
Report
MBX Biosciences (MBX) had its "buy" rating reaffirmed by TD Cowen.
3/12
08:38 am
mbx
MBX Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Medium
Report
MBX Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
3/12
08:00 am
mbx
MBX Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Highlights
Low
Report
MBX Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Highlights
3/10
08:32 am
mbx
MBX Biosciences Appoints Karen Basbaum as Chief Business Officer [Yahoo! Finance]
Medium
Report
MBX Biosciences Appoints Karen Basbaum as Chief Business Officer [Yahoo! Finance]
3/10
08:00 am
mbx
MBX Biosciences Appoints Karen Basbaum as Chief Business Officer
Medium
Report
MBX Biosciences Appoints Karen Basbaum as Chief Business Officer
3/9
12:06 pm
mbx
MBX Biosciences (MBX) was given a new $50.00 price target by Truist Financial Corporation.
Medium
Report
MBX Biosciences (MBX) was given a new $50.00 price target by Truist Financial Corporation.
3/9
10:21 am
mbx
CORRECTING & REPLACING -- MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
Medium
Report
CORRECTING & REPLACING -- MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
3/9
08:02 am
mbx
MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism [Yahoo! Finance]
Medium
Report
MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism [Yahoo! Finance]
3/9
08:00 am
mbx
MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
Medium
Report
MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
3/7
07:03 pm
mbx
MBX Biosciences CFO Shift Puts Funding And Execution In Focus [Yahoo! Finance]
Medium
Report
MBX Biosciences CFO Shift Puts Funding And Execution In Focus [Yahoo! Finance]
2/28
07:16 pm
mbx
MBX Biosciences Calls 2026 “Pivotal” With Phase 3 Plans, Obesity Program, and $460M Cash Runway [Yahoo! Finance]
Low
Report
MBX Biosciences Calls 2026 “Pivotal” With Phase 3 Plans, Obesity Program, and $460M Cash Runway [Yahoo! Finance]
2/24
12:05 pm
mbx
MBX Biosciences (NASDAQ:MBX) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
MBX Biosciences (NASDAQ:MBX) had its "buy" rating reaffirmed by analysts at UBS Group AG.
2/23
08:13 am
mbx
MBX Biosciences to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
Medium
Report
MBX Biosciences to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
2/23
08:00 am
mbx
MBX Biosciences to Participate in Upcoming March Investor Conferences
Medium
Report
MBX Biosciences to Participate in Upcoming March Investor Conferences
2/11
08:53 am
mbx
MBX Biosciences to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
MBX Biosciences to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/11
08:00 am
mbx
MBX Biosciences to Participate in Upcoming Investor Conferences
Medium
Report
MBX Biosciences to Participate in Upcoming Investor Conferences
1/29
07:41 am
mbx
MBX Biosciences (NASDAQ:MBX) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Medium
Report
MBX Biosciences (NASDAQ:MBX) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.